A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder.
about
Overactive bladderFinding unrecognized information in overactive bladder clinical trial data: a new approach to understanding placebo and treatment effects.The placebo effect in overactive bladder syndrome.Efficacy and safety of Baweidihuang-wan in women with overactive bladder: a randomized, double blind, placebo controlled trialAge and sex as moderators of the placebo response – an evaluation of systematic reviews and meta-analyses across medicineThe placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studiesPlacebo Medication and Sham Surgery Responses in Benign Prostatic Hyperplasia Treatments: Implications for Clinical Trials.Patient-optimized doses of fesoterodine improve bladder symptoms in an open-label, flexible-dose study.Early onset of fesoterodine efficacy in subjects with overactive bladder.Validity and reliability of patient selected goals as an outcome measure in overactive bladder.Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder in Asia.Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis.Overactive Bladder Syndrome: Evaluation and Management.A Pilot Randomized Controlled Trial to Explore Cognitive and Emotional Effects of Probiotics in FibromyalgiaTreating Urge Incontinence in Older Women: A Cost-Effective Investment in Quality-Adjusted Life-Years (QALY)
P2860
Q26766174-F9B76D3B-A317-4749-9C25-2F954AC86DB0Q30570112-1E1FC00E-E783-4AEE-90C8-138405113F11Q34197411-D4296E52-CC47-4653-99AA-9D1BAB30AB48Q34415046-4C785A34-4726-407E-AB32-C677C472BD37Q35513153-97E1A7DE-5116-4E49-A825-5ABBD962F76AQ37296828-60E6FFAC-6239-4813-A4C2-141CB972B703Q38573073-38CA5B99-3636-45F9-A9E9-4190B0E7058FQ39279571-0DA6C43D-07D1-4728-9000-5396FE4A4CBCQ42676434-77916228-2B3E-4065-86B4-3A04446FC283Q42688194-38D0CCD9-04BD-438F-B282-2AD15E294CC8Q43928336-8F1FE63A-C3C4-40FA-869A-EEC9FAC503D2Q48300325-37310FFD-2B02-45A8-B527-6170DA0862E6Q53945500-ACA02E3E-C384-4A91-AC70-A51DD1D51061Q57210305-F9028A6C-EF92-453D-896F-ECA6A7CFB821Q59104199-D55ED625-7963-424C-AA6F-6022F723A811
P2860
A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
A meta-analysis of the placebo ...... trials for overactive bladder.
@ast
A meta-analysis of the placebo ...... trials for overactive bladder.
@en
type
label
A meta-analysis of the placebo ...... trials for overactive bladder.
@ast
A meta-analysis of the placebo ...... trials for overactive bladder.
@en
prefLabel
A meta-analysis of the placebo ...... trials for overactive bladder.
@ast
A meta-analysis of the placebo ...... trials for overactive bladder.
@en
P2093
P2860
P356
P1476
A meta-analysis of the placebo ...... trials for overactive bladder.
@en
P2093
Bimal Malhotra
Dana Creanga
Martin Carlsson
P2860
P2888
P356
10.1186/1471-2288-9-55
P50
P577
2009-07-22T00:00:00Z
P5875
P6179
1038649424